Sign up for the latest news
You can unsubscribe at any time using the link at the bottom of any newsletter or contacting info@predictimmune.com
Updates and more on the company blog
Why “the new normal” can be better than the past for patients with inflammatory bowel disease
With the acceleration of remote patient management, the cost of biosimilars coming down and the arrival of a working prognostic test for Crohn’s and ulcerative colitis, there hasn’t been a better opportunity to improve the way we treat IBD patients Inflammatory bowel...
Counting the Cost of Biologic Therapy in IBD
Inflammatory bowel disease (IBD) puts a significant burden on healthcare systems due to its chronic nature and expensive treatments. Back in 2004, the main direct cost of IBD care came from hospitalisations and surgery1. The approach to IBD care has progressed in the...
Pregnancy outcomes in women with IBD: a 10‐year nationwide population‐based cohort study
Crohn's disease (CD) and ulcerative colitis (UC) often affect women of childbearing age. A new population-based study published in Alimentary Pharmacology & Therapeutics looked at the outcomes for pregnant women with inflammatory bowel disease (IBD) compared the...